FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/06/025611 [Registered on: 04/06/2020] Trial Registered Prospectively
Last Modified On: 03/06/2020
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Comparison of efficacy of erector spinae plane block with paravertebral block for postoperative pain management in patients undergoing breast cancer surgeries 
Scientific Title of Study   Comparison of efficacy of erector spinae plane block with paravertebral block for postoperative analgesia in patients undergoing breast cancer surgeries 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Arjun Singh 
Designation  post graduate resident 
Affiliation  Safdarjung hospital and Vardhman Mahavir Medical College 
Address  Department of Anaesthesia and intensive care. Ground floor, main operation theatre building. Safdarjung hospital and Vardhman Mahavir Medical College, New Delhi 110029

New Delhi
DELHI
110029
India 
Phone  9560316794  
Fax    
Email  arjun.mander95@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Nidhi Agrawal 
Designation  Specialist Grade 1 ( Anaesthesia) 
Affiliation  Safdarjung hospital and Vardhman Mahavir Medical College 
Address  Department of Anaesthesia and intensive care. Ground floor, main operation theatre building. Safdarjung hospital and Vardhman Mahavir Medical College, New Delhi 110029

New Delhi
DELHI
110029
India 
Phone  9811030408  
Fax    
Email  nidhi.agrawal1970@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Arjun Singh 
Designation  post graduate resident 
Affiliation  Safdarjung hospital and Vardhman Mahavir Medical College 
Address  Department of Anaesthesia and intensive care. Ground floor, main operation theatre building. Safdarjung hospital and Vardhman Mahavir Medical College, New Delhi 110029

New Delhi
DELHI
110029
India 
Phone  9560316794  
Fax    
Email  arjun.mander95@gmail.com  
 
Source of Monetary or Material Support  
Safdarjung hospital and Vardhman Mahavir Medical College New Delhi India 
 
Primary Sponsor  
Name  Safdarjung hospital and Vardhman Mahavir Medical College New Delhi India 
Address  Department of Anaesthesia and intensive care Ground floor, main operation theatre building. Safdarjung hospital and Vardhman Mahavir Medical College New Delhi 110029, India 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Arjun Singh  Safdarjung Hospital and Vardhmann Mahavir Medical College New Delhi 110023  Department of Anaesthesia and Intensive Care . Ground floor, main operation theatre building, Safdarjung Hospital And Vardhman Mahavir Medical College New Delhi.
New Delhi
DELHI 
9560316794

arjun.mander95@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C509||Malignant neoplasm of breast of unspecified site,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  USG guided erector spinae plane block in patients undergoing breast cancer surgeries  ESP block will be placed with patient in lateral position with side to be operated towards up. Under all aseptic conditions, using an ultrasound system , the linear array high frequency probe will be placed in a transverse orientation to identify the spinous process, lamina, and transverse process of 4th thoracic vertebra. The tip of the transverse process will be centred on the ultrasound screen, and the transducer will be rotated 90 degrees into a longitudinal orientation to obtain a parasagittal view. The 3 layers of muscles will be identified as trapezius, rhomboidus major and erector spinae. A 10cm long, 22 gauge echogenic needle will be inserted out of plane, to contact the transverse process. After hydro-dissecting the plane with normal saline, 21 ml of 0.5 precent ropivacaine with 1µg per kg of clonidine diluted to 1 ml ( making total volume of drug to 22ml) will be deposited deep to the erector spinae muscle , lifting it off the transverse process of t4 vertebra. Heart rate, blood pressure (systolic, diastolic, mean), sp02 and etco2 will be monitored continuously in the intraoperative period and will be noted before administration of regional block and then after administration of regional block every 10 minutes for next 60 minutes and thereafter every 30 minutes till the end of surgery. Entropy will be used to monitor the depth of anaesthesia and will be maintained between 40 and 60 by adjusting the concentration of isoflurane. If there is any increase in hr or bp more than 20 percent baseline then intravenous injection fentanyl 0.5μg per kg will be given. Any hypotension ( fall in mean arterial pressure more than 20 percent of baseline) will be treated with boluses of ringer lactate solution and, if required with intravenous mephentermine 3 to 6 mg. Symptomatic bradycardia will be treated with intravenous atropine 0.6 mg. At the end of surgery 100 percent oxygen will be given to all the patients and residual neuromuscular blockade will be reversed with intravenous neostigmine 0.05mg per kg and glycopyrrolate 0.01mg per kg. On adequate neuromuscular reversal, the supraglottic airway device will be removed and patients will be shifted to the recovery room.  
Comparator Agent  USG guided Paravertebral block in patients undergoing breast cancer surgery  Patients will be kept in lateral position with the side to be operated up, on the operation table. under all aseptic conditions, using an ultrasound system , the linear array high frequency probe will be placed in a parasagittal plane , approximately 5 cm lateral to the spinous processes of t3 and t4 vertebrae to identify ribs, parietal pleura and intercostal spaces. The transducer is then moved progressively medially to about 2.5 cm lateral to spinous process to identify transverse processes of t3 and t4 vertebrae . Transverse processes appear square and deeper then ribs (round, superficial). The thoracic paravertebral space will be identified as a wedge shaped hypoechoic space between the superior costotransverse ligament and the pleura. A 10 cm long, 22-gauge, echogenic needle will be inserted using an out of-plane approach to contact the transverse process and then walk off the transverse process 1 to 1.5 cm deeper to inject the local anaesthetic agent. During needle advancement, hydro-dissection will be used to locate the needle tip under ultrasound guidance, until the tip penetrates the superior costotransverse ligament. Penetration of the costotransverse ligament with the needle tip in the paravertebral space, will be confirmed by hydro-dissection technique by injecting normal saline and seeing anterior displacement of pleura. Negative aspiration for blood will be confirmed and 21 ml of 0.5 percent ropivacaine with 1µg per kg of clonidine diluted to 1 ml of saline ( making total volume of drug to 22 ml) will be injected in paravertebral space. Proper spread of the drug in the paravertebral space will be confirmed by anterior displacement of the pleura.  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Female 
Details  This study will be conducted in adult female patients of age 18 - 60 years weighing > 50 kgs, fulfilling criteria of American Society of Anaesthesiology (ASA) physical status i and ii undergoing elective modified radical mastectomy (MRM) for breast cancer under general anaesthesia with controlled ventilation. 
 
ExclusionCriteria 
Details  1. coagulation disorder, local infection, allergy to study drugs
2. anatomic deformity of spine or chest wall
3. pregnant patient
4.morbid obesity
5. liver or renalinsufficiency, respiratory/ cardiac/ psychiatric disease.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Duration of Analgesia- time from administration of the block till time of administration of first rescue analgesia to the patient will be noted (primary objective).  Preoperative vitals to be noted at time 0.
Intraoperative vitals to be noted at before block, 10, 20, 30, 40, 50, 60, 90, 120, 150, 180 mins after the block.
postoperative:
1. VAS assessment at 0,1,2,4,6.,12,24 hours
2. PONV score assessed at 0,6,12,24 hours. 
 
Secondary Outcome  
Outcome  TimePoints 
1) Visual Analogue Scale (VAS)
2) Total intraoperative requirement of fentanyl
3) Total amount of tramadol required in first 24 hours postoperatively
4) Postoperative nausea and vomiting
5) Adverse effects if any
6) Patient satisfaction using numeric rating scale (nrs)
7) Number of dermatomal segments blocked postoperatively
 
VAS at 0,1,2,4,6,12,24 hours
Postoperative nausea and vomiting at 0,6,12,24 hours
 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Post Marketing Surveillance 
Date of First Enrollment (India)   09/06/2020 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  
This study is aimed at comparing the efficacy of erectoe spinae plane block with paravertebral block for postoperative pain relief in patients undergoing breast cancer surgery.
Study will be conducted in adult females of age 18-60 years weighing>50 kgs fulfilling the criteria of  ASA physical status I and II undergoing breast cancer surgery under general anaesthesia with controlled ventilation.
Patient taken to O.T. and baseline parameters of HR, BP, SPO2 noted.
Standard general anaesthesia administered, inj dexamethasone 0.1mg/kg given, inj paracetamol 1gm i.v. over 30 mins administered.
Randomized into two groups:
GROUP E (USG guided erector spinae block) in lateral position using 21 ml of 0.5% ropivacaine + clonidine 1mcg/kg made to total of 22ml.
GROUP P(USG guided paravertebral block) in lateral position using 21ml of 0.5% ropivacaine +1 mcg/kg clonidine made to total of 22ml.
Intraoperative fentanyl requirement to be noted
Parameters to be noted after reversal:
1.Duration of analgesia
2.VAS score
3.Total tramadol requirement
4.PONV score
5.Patient satisfaction using NRS
6.Intraoperative fentanyl requirement
 
Close